While the majority of GRHL2 mutations identified to date appear to result in diminished function, non-coding intronic variants that increase transcription in vitro have been identified in individuals with corneal endothelial dystrophy (47). The gene discussed is GRHL2; the disease is Fuchs endothelial corneal dystrophy.